您的位置: 首页 > 农业专利 > 详情页

5-BROM-2,6-DI-(1H-PIRAZOL-IL)PIRIMIDIN-4-AMINAS, SKIRTAS PANAUDOTI VĖŽIO GYDYMUI
专利权人:
Novartis AG;Palobiofarma, S.L.
发明人:
BILIC, Sanela,CAMACHO GOMEZ, Juan Alberto,CAMERON, John Scott,CASTRO-PALOMINO LARIA, Julio Cesar,HOWARD, JR.
申请号:
LT16766384
公开号:
LT3334431T
申请日:
2016.08.10
申请国别(地区):
LT
年份:
2019
代理人:
摘要:
To provide new therapies for the treatment of cancer with a low survival rate, represented by non-small cell lung cancer (NSCLC).SOLUTION: A combination product comprises a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof, and one or more immunotherapeutic agents selected from the group consisting of an anti-CTLA4 antibody, an anti-PD-1 antibody and an anti-PD-L1 antibody.SELECTED DRAWING: None
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充